| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |